Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Voyageur Pharmaceuticals Secures USD $1.9 Million Sales Contract for SmoothX 2% (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Sentry Select Primary Metals Corp
T.PME
Alternate Symbol(s):
SPMLF
Sentry Select Primary Metals Corp. (the Fund) is a Canada-based financial investment company. The Fund invests in an actively managed portfolio consisting primarily of securities of mining and exploration issuers, with a current focus on gold issuers. The Fund’s investment objective is to provide shareholders with long-term capital appreciation, and monthly cash distributions. CI Investments Inc. is the manager of the Fund.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
New Post
TSX:PME - Post by User
Sentry Select Primary Metals Corp
> Big pop in PME NAV today...
<< Previous
Bullboard Posts
Next >>
(3)
•••
Audax77
X
View Profile
View Bullboard History
Comment by
Audax77
on May 02, 2020 10:03am
62 Views
Post# 30979183
RE:Big pop in PME NAV today...
RE:Big pop in PME NAV today...
PME +4.409%
Mutual Fund + 3.924%
MMP +3.762%
Quite the difference there. I was expecting 4 to 4.5%, but also thought MMP would be on top with over 11% weight in Wheaton.
Comment on this Post
<< Previous
Bullboard Posts
Next >>
Voyageur Pharmaceuticals signs $2.6M contract in Latin America
Morning Market Outlook for May 28, 2024
Multi-bagger industrial stock adds $90M in new contracts
Datametrex secures ‘Cereal Crunch’ mobile blockchain game acquisition
Drilling company poised to capitalize on market conditions
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
{{ dialogTitle }}
×
Reject Reason
{{ policy.description }}
{{reasonError}}
Additional Comments
{{feedbackError}}
{{buttonTitle}}
Cancel
{{submitMsg}}
Featured News Links
April Sees Record Revenue for Cannabis Edibles Leader and Eyes Record Profitability in 2024
This Gambling Tech Stock Might be the Safest Bet you’ll make this Year